Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma
Status:
Terminated
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to show that chemotherapy delivered directly through the artery
supplying the eye (ophthalmic artery) to patients with retinoblastoma is a safe and effective
treatment alternative to conventional systemic chemotherapy, external beam radiation, and
surgical removal of the eye.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins